Abstract The asymmetric Favorskii rearrangement of opticallyactive α‐haloketones, which are easily prepared from chiral menthyl‐4‐toluenesulfoxide in several steps using primary or secondary amines, yields their corresponding secondary or tertiary chiral amides. The secondary chiral amides were converted to acids or amines using acylation followed by hydrolysis or reduction. In addition, the tertiary
nanotubes from chiral bisurea monomers. Furthermore, similar helical nanotubes (with the same circular dichroism signature) can be obtained from racemic monomers in a chiralsolvent. Competition experiments reveal the relative strength of the helical bias induced by the chiral monomer or by the chiralsolvent. The nanotube handedness is imposed by the monomer chirality, whatever the solventchirality. However
4,6-DIAMINO-PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS AND THEIR UTILISATION AS MODULATORS OF TOLL-LIKE RECEPTORS
申请人:Gilead Sciences, Inc.
公开号:EP3321265A1
公开(公告)日:2018-05-16
The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D] pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
BIODEGRADABLE POLY(BETA-AMINO ESTERS) AND USES THEREOF
申请人:MASSACHUSETTS INSTITUTE OF TECHNOLOGY
公开号:EP1639029B1
公开(公告)日:2007-07-11
[EN] MODULATORS OF TOLL-LIKE RECPTORS FOR THE TREATMENT OF HIV<br/>[FR] MODULATEURS DE RÉCEPTEURS DE TYPE TOLL POUR LE TRAITEMENT DU VIH
申请人:GILEAD SCIENCES INC
公开号:WO2017048727A1
公开(公告)日:2017-03-23
Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.